Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ANAB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
39 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 12 days ago
Red flags: 3
213 filers reported a long position in ANAB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-04-20 3-for-2 split, 2026-04-20 15-for-10 split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| EcoR1 Capital, LLC | $531.9M | 7.9M | -55.6% |
| BlackRock, Inc. | $124.5M | 1.8M | -51.3% |
| TANG CAPITAL MANAGEMENT LLC | $89.8M | 1.3M | -55.6% |
| STATE STREET CORP | $86.8M | 1.3M | -42.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $61.2M | 906.2K | -52.8% |
| Affinity Asset Advisors, LLC | $55.8M | 826.1K | -60.9% |
| Sanofi | $55.5M | 821.9K | -55.6% |
| MILLENNIUM MANAGEMENT LLC | $54.5M | 807.3K | -24.6% |
| Woodline Partners LP | $48.4M | 717K | -7.4% |
| 683 Capital Management, LLC | $44.6M | 660K | -53.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.